AllianceBernstein’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $721K | Hold |
63,320
| – | – | ﹤0.01% | 2458 |
|
|
2025
Q1 | $752K | Hold |
63,320
| – | – | ﹤0.01% | 2376 |
|
|
2024
Q4 | $1.19M | Hold |
63,320
| – | – | ﹤0.01% | 2242 |
|
|
2024
Q3 | $1.42M | Hold |
63,320
| – | – | ﹤0.01% | 2145 |
|
|
2024
Q2 | $1.32M | Buy |
63,320
+16,860
| +36% | +$352K | ﹤0.01% | 2167 |
|
|
2024
Q1 | $683K | Hold |
46,460
| – | – | ﹤0.01% | 2449 |
|
|
2023
Q4 | $479K | Hold |
46,460
| – | – | ﹤0.01% | 2627 |
|
|
2023
Q3 | $365K | Sell |
46,460
-75,000
| -62% | -$590K | ﹤0.01% | 2723 |
|
|
2023
Q2 | $1.21M | Buy |
121,460
+85,160
| +235% | +$851K | ﹤0.01% | 2173 |
|
|
2023
Q1 | $322K | Sell |
36,300
-126,600
| -78% | -$1.12M | ﹤0.01% | 2745 |
|
|
2022
Q4 | $1.79M | Buy |
162,900
+80,000
| +97% | +$878K | ﹤0.01% | 1988 |
|
|
2022
Q3 | $1.08M | Buy |
82,900
+9,639
| +13% | +$126K | ﹤0.01% | 2241 |
|
|
2022
Q2 | $928K | Buy |
73,261
+40,361
| +123% | +$511K | ﹤0.01% | 2386 |
|
|
2022
Q1 | $461K | Buy |
32,900
+100
| +0.3% | +$1.4K | ﹤0.01% | 2705 |
|
|
2021
Q4 | $950K | Sell |
32,800
-59,724
| -65% | -$1.73M | ﹤0.01% | 2478 |
|
|
2021
Q3 | $2.77M | Buy |
92,524
+59,724
| +182% | +$1.79M | ﹤0.01% | 1955 |
|
|
2021
Q2 | $870K | Buy |
+32,800
| New | +$870K | ﹤0.01% | 2587 |
|